141 related articles for article (PubMed ID: 8655711)
21. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
Leroy X
Ann Pathol; 2017 Jun; 37(3):245-248. PubMed ID: 28554778
[No Abstract] [Full Text] [Related]
22. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction.
Hoon DS; Sarantou T; Doi F; Chi DD; Kuo C; Conrad AJ; Schmid P; Turner R; Guiliano A
Int J Cancer; 1996 Oct; 69(5):369-74. PubMed ID: 8900369
[TBL] [Abstract][Full Text] [Related]
23. Combination of serum hCG beta and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma.
Vartiainen J; Lassus H; Lehtovirta P; Finne P; Alfthan H; Butzow R; Stenman UH
Int J Cancer; 2008 May; 122(9):2125-9. PubMed ID: 18098286
[TBL] [Abstract][Full Text] [Related]
24. B Subunit of Human Chorionic Gonadotropin Promotes Tumor Invasion and Predicts Poor Prognosis of Early-Stage Colorectal Cancer.
Li J; Yin M; Song W; Cui F; Wang W; Wang S; Zhu H
Cell Physiol Biochem; 2018; 45(1):237-249. PubMed ID: 29357321
[TBL] [Abstract][Full Text] [Related]
25. [Should elevated beta-HCG levels be an exclusion criteria in clinical trials? A case report of paraneoplastic secretion associated with lung adenocarcinoma].
Taverne J; Delourme J; Dhalluin X; Copin MC; Scherpereel A; Lafitte JJ; Cortot AB
Rev Pneumol Clin; 2013 Feb; 69(1):36-40. PubMed ID: 23337393
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer metastasis to thyroid gland.
Selimoglu H; Duran C; Saraydaroglu O; Guclu M; Kiyici S; Ersoy C; Eren MA; Tuncel E; Imamoglu S
Tumori; 2007; 93(3):292-5. PubMed ID: 17679467
[TBL] [Abstract][Full Text] [Related]
27. Differentiating tumor heterogeneity in formalin-fixed paraffin-embedded (FFPE) prostate adenocarcinoma tissues using principal component analysis of matrix-assisted laser desorption/ionization imaging mass spectral data.
Panderi I; Yakirevich E; Papagerakis S; Noble L; Lombardo K; Pantazatos D
Rapid Commun Mass Spectrom; 2017 Jan; 31(2):160-170. PubMed ID: 27791282
[TBL] [Abstract][Full Text] [Related]
28. A preliminary investigation of Beta-hCG expression in patients with osteosarcoma.
Masrouha KZ; Khattab R; Tawil A; Abdallah A; Saghieh S; Haidar R; Abboud M; Khoury NJ
J Bone Joint Surg Br; 2012 Mar; 94(3):419-24. PubMed ID: 22371553
[TBL] [Abstract][Full Text] [Related]
29. Estrogen receptor beta expression in prostate adenocarcinoma.
Asgari M; Morakabati A
Diagn Pathol; 2011 Jul; 6():61. PubMed ID: 21733187
[TBL] [Abstract][Full Text] [Related]
30. Endometrial adenocarcinoma associated with elevated serum concentrations of the free beta subunit of human chorionic gonadotropin.
Grenache DG; Moller KA; Groben PM
Am J Clin Pathol; 2004 May; 121(5):748-53. PubMed ID: 15151215
[TBL] [Abstract][Full Text] [Related]
31. CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome.
Ogino H; Shibamoto Y; Takanaka T; Suzuki K; Ishihara S; Yamada T; Sugie C; Nomoto Y; Mimura M
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):803-8. PubMed ID: 15936563
[TBL] [Abstract][Full Text] [Related]
32. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
33. Elevated levels of human chorionic gonadotropin-beta, a marker of active neurohypophyseal germinoma, detected by immune complex transfer enzyme immunoassay.
Yoshizawa A; Yokoya S; Oyama K; Yamada S
Pituitary; 2004; 7(3):165-169. PubMed ID: 16010454
[TBL] [Abstract][Full Text] [Related]
34. Detection of apoptosis by the TUNEL technique in clinically localised prostatic cancer before and after combined endocrine therapy.
Colecchia M; Frigo B; Del Boca C; Guardamagna A; Zucchi A; Colloi D; Leopardi O
J Clin Pathol; 1997 May; 50(5):384-8. PubMed ID: 9215120
[TBL] [Abstract][Full Text] [Related]
35. PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study.
Kim SH; Park WS; Park BR; Joo J; Joung JY; Seo HK; Chung J; Lee KH
Asian J Androl; 2017; 19(4):458-462. PubMed ID: 27232854
[TBL] [Abstract][Full Text] [Related]
36. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
37. Detection of beta-human chorionic gonadotropin mRNA as a marker for cutaneous malignant melanoma.
Doi F; Chi DD; Charuworn BB; Conrad AJ; Russell J; Morton DL; Hoon DS
Int J Cancer; 1996 Feb; 65(4):454-9. PubMed ID: 8621227
[TBL] [Abstract][Full Text] [Related]
38. Nucleolar organizer regions: preliminary results of the clinical use of a new marker for prostatic carcinoma (40 cases).
Marandola P; Lardennois B; Ploton D; Derenzini M; Treré D; Campo B; Corrada P; Valentino V; Roggia A; Broggini P
Eur Urol; 1992; 21 Suppl 1():71-4. PubMed ID: 1425841
[TBL] [Abstract][Full Text] [Related]
39. A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma.
Doganavsargil B; Simsir A; Boyacioglu H; Cal C; Hekimgil M
BJU Int; 2006 Mar; 97(3):644-8. PubMed ID: 16469041
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Genega EM; Hutchinson B; Reuter VE; Gaudin PB
Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
